Catherine Cintron v. HHS - DTaP, autoimmune hemolytic anemia (2017)
Case summary [AI summaries can sometimes make mistakes]
On May 24, 2016, Catherine Cintron, as the parent and legal representative of her minor son E.C., filed a petition for compensation under the National Vaccine Injury Compensation Program. Petitioner alleged that E.C. developed autoimmune hemolytic anemia after receiving influenzae b (Hib), diphtheria-tetanus-acellular pertussis (DTaP), inactivated polio virus (IPV), pneumococcal (Prevnar), and rotavirus vaccinations on May 31, 2013.
The respondent denied that the immunizations caused E.C.'s injury. The parties reached a settlement agreement, and on June 12, 2017, they filed a joint stipulation.
As part of the settlement, the respondent agreed to issue a payment of $65,000.00 as compensation for all damages. Special Master Mindy Michaels Roth adopted the joint stipulation and awarded compensation in the agreed-upon amount.
The decision was filed on June 13, 2017. Petitioner's counsel was Elizabeth Muldowney of Rawls McNelis and Mitchell, P.C.
Respondent's counsel was Michael P. Milmoe of the U.S.
Department of Justice.
Theory of causation
Petitioner alleged that E.C. developed autoimmune hemolytic anemia after receiving influenzae b (Hib), diphtheria-tetanus-acellular pertussis (DTaP), inactivated polio virus (IPV), pneumococcal (Prevnar), and rotavirus vaccinations on May 31, 2013. Respondent denied causation. The parties reached a joint stipulation to settle the case. The public decision does not describe the specific theory of causation, medical experts, clinical details of the injury, or the mechanism of injury. The settlement resulted in an award of $65,000.00. The decision was issued by Special Master Mindy Michaels Roth on June 13, 2017. Petitioner's counsel was Elizabeth Muldowney, and respondent's counsel was Michael P. Milmoe.
Source PDFs
USCOURTS-cofc-1_16-vv-00608